Three Inflation Methods of Ambú Auragain™ and Its Adverse Effects
Three Inflation Methods of the Laryngeal Mask Airway Ambú Auragain™ and Its Pharyngolaryngeal Adverse Effects
1 other identifier
interventional
210
1 country
1
Brief Summary
Laryngeal mask is a common supraglottic device (SGD) used in the daily practice for airway management. Consecutive generations have permitted an expansion of its use. At the moment, the SGD is being used in several situations, which include general anesthesia, cardiopulmonary resuscitation, and difficult airway management. To insert the SGD safely in these situations, the Fourth National Audit Project has encouraged the use of second-generation SGD equipped with the passage of a nasogastric tube. Ambu Auragain™ is a recent second-generation SGD with an incorporated gastric drainage channel and the capability of working as a conduit for tracheal intubation. It has higher leak pressure than the ones of first generation, which is a key marker of efficacy and safety of its use; a higher leak pressure suggests a better seal between the artificial airway and patient's airway. However, there are still few reports of which volume of cuff is the most appropriate for it use. The cuff inflating volume is not standardized and it is common practice to inflate the SGD cuff according to the manufacturer's recommendations, without using a manometer. A hyperinflation of the laryngeal mask cuff was associated with complications ranging from sore throat, or dysphagia and dysphonia, to more serious complications such as paralysis of the vocal cord, arytenoid cartilages dislocation, recurrent laryngeal nerve injury and hypoglossal nerve injury. Also, the excess of volume or pressure is related to poor ventilation and increase the risk of gastric insufflation. The aim of this study is to evaluate the best cuff inflation method, in order to limit the intracuff pressure beyond the recommended maximum pressure (PM \< 60 cmH2O) and to allows decrease the pharyngo-laryngeal complications. The Primary outcome is to compare three different cuff inflating methods using Auragain™ laryngeal mask during fibro bronchoscopy and endobronchial ultrasound (EBUS) procedures, and to control the intracuff pressure, and the effect on pharyngo-laryngeal complications. The three different cuff inflating methods are: 1) residual volume group (RV group ) 2) half of the maximum volume group (MV group) 3) unchanged volume group (NV group)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 18, 2021
CompletedFirst Submitted
Initial submission to the registry
March 10, 2021
CompletedFirst Posted
Study publicly available on registry
March 12, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 20, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
October 30, 2021
CompletedJanuary 11, 2022
January 1, 2022
9 months
March 10, 2021
January 10, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
intracuff pressure
Compare Intracuff Pressure of three different cuff inflating volume methods with laryngeal mask, to control the intracuff pressure
procedure ( after correct placement of SGD)
Secondary Outcomes (5)
time of insertion
procedure ( from pick up to correct placement of SGD
insertion attempts
procedure ( from pick up to correct placement of SGD
OLP
procedure ( after correct placement of SGD)
positioning of the LMA
procedure (after correct placement of SGD)
pharyngolaryngeal complications
day 2
Study Arms (3)
cuff inflation by the residual volume
EXPERIMENTALLMA will be inserted with the initial inflating volume correspondent to residual volume group (RV group): volume result of equilibrating pressure between intracuff pressure and atmospheric pressure. A 20 mL syringe without plunger is connected to the laryngeal cuff for 5 minutes
cuff inflation by half of the maximum volume
EXPERIMENTALLMA will be inserted with the initial inflating volume correspondent to half of the maximum volume recommended by manufacturers (MV group)
unchanged cuff inflation volume
PLACEBO COMPARATORLMA will be inserted unchanged (NV group): LMA is unpacked and used without inflating or deflating the cuff.
Interventions
Intracuff pressure is measured by a pressure manometer.
Eligibility Criteria
You may qualify if:
- Patients age between 18 and 90 years
- American Society of Anesthesiologist (ASA) physical status I-III
- fiberoptic bronchoscopy procedure and EBUS-TBNA procedure programmed.
- Fasted for 6 hours before procedure.
- Management of the airway for the same anesthetic.
- Use de laryngeal mask airway for boarding and maintenance of airway permeability.
You may not qualify if:
- LMA is contraindicated because high risk of aspiration (full stomach, gastroesophageal reflux history, pregnant)
- predictors of difficult airway such restricted mouth opening (\< 2 cm of interincisal distance)
- patients with any pathology of the neck, upper respiratory or upper alimentary tract
- dysphagia o hoarseness.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Teresa Prim Martinez
Madrid, 28034, Spain
Related Publications (6)
Seet E, Yousaf F, Gupta S, Subramanyam R, Wong DT, Chung F. Use of manometry for laryngeal mask airway reduces postoperative pharyngolaryngeal adverse events: a prospective, randomized trial. Anesthesiology. 2010 Mar;112(3):652-7. doi: 10.1097/ALN.0b013e3181cf4346.
PMID: 20179502BACKGROUNDGhai B, Sethi S, Ram J, Wig J. Cuff filling volumes for pediatric classic laryngeal mask airways: comparison of clinical end points versus adjusted cuff pressure. Paediatr Anaesth. 2013 Feb;23(2):122-6. doi: 10.1111/pan.12023. Epub 2012 Sep 18.
PMID: 22985184BACKGROUNDKeller C, Puhringer F, Brimacombe JR. Influence of cuff volume on oropharyngeal leak pressure and fibreoptic position with the laryngeal mask airway. Br J Anaesth. 1998 Aug;81(2):186-7. doi: 10.1093/bja/81.2.186.
PMID: 9813520BACKGROUNDLi BB, Yan J, Zhou HG, Hao J, Liu AJ, Ma ZL. Application of Minimum Effective Cuff Inflating Volume for Laryngeal Mask Airway and its Impact on Postoperative Pharyngeal Complications. Chin Med J (Engl). 2015 Oct 5;128(19):2570-6. doi: 10.4103/0366-6999.166034.
PMID: 26415792BACKGROUNDRuananukun N, Watcharotayangul J, Jeeranukosol S, Komonhirun R. Correlation and variation of cuff inflating volumes and pressures in different adult models of laryngeal mask: a prospective randomized trial. BMC Anesthesiol. 2020 May 7;20(1):108. doi: 10.1186/s12871-020-01028-4.
PMID: 32380954BACKGROUNDShariffuddin II, Teoh WH, Tang E, Hashim N, Loh PS. Ambu(R) AuraGain versus LMA Supreme Second Seal: a randomised controlled trial comparing oropharyngeal leak pressures and gastric drain functionality in spontaneously breathing patients. Anaesth Intensive Care. 2017 Mar;45(2):244-250. doi: 10.1177/0310057X1704500215.
PMID: 28267947BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
TERESA PRIM MARTINEZ, MD
HOSPITAL La Paz
- STUDY CHAIR
NICOLÁS BROGLY, MD
Hospital La Paz
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
March 10, 2021
First Posted
March 12, 2021
Study Start
January 18, 2021
Primary Completion
October 20, 2021
Study Completion
October 30, 2021
Last Updated
January 11, 2022
Record last verified: 2022-01